A patient came in last fall with a serum B12 level of 198 pg/mL — within the lab's "normal" range, which starts at 180 — and a constellation of symptoms that had been written off for two years as anxiety: tingling in both feet, fatigue that did not resolve with sleep, brain fog, and a memory problem that scared her. She had been taking a sublingual B12 lozenge daily for ten months on the recommendation of a previous provider. The lozenge had not changed her level meaningfully. Her methylmalonic acid was elevated, her homocysteine was high, and she had a known history of long-term proton pump inhibitor use that nobody had connected to the picture.
That is the case I want patients to think about when they ask the question that titles this article. The question of B12 injection versus sublingual is not really about which delivery is "better" in the abstract. It is about which delivery actually moves the patient's level into a functional range given her specific physiology. The answers are different for different patients, and the reference range printed on the lab report is misleading enough to be dangerous.
What B12 actually does and why deficiency is missed
B12 (cobalamin) is a cofactor in two essential enzymatic reactions: methionine synthase (which converts homocysteine to methionine and supports methylation throughout the body) and methylmalonyl-CoA mutase (which is essential for fatty acid metabolism and myelin maintenance). When B12 is deficient, the downstream consequences are measurable and clinically significant — neurologic symptoms (peripheral neuropathy, cognitive changes, mood changes), hematologic changes (macrocytic anemia, though this can be masked by concurrent folate supplementation), elevated homocysteine (a cardiovascular risk factor), and elevated methylmalonic acid.
The reason deficiency is so frequently missed is that the reference range used by most labs starts at around 180-200 pg/mL. That floor was established decades ago and is, by current functional standards, far too low. Functional medicine literature increasingly suggests that levels below 400-500 pg/mL frequently produce symptoms in clinically vulnerable patients, particularly those with absorption compromise. A patient with a level of 250 pg/mL is told she is "normal" and her symptoms are dismissed. Her methylmalonic acid is never checked.
When I evaluate a patient with fatigue, neuropathy, or unexplained cognitive symptoms, I am ordering serum B12, methylmalonic acid, homocysteine, and folate together. The reference range alone does not tell me what I need to know.
Who actually has absorption problems — and most do not realize it
The bioavailability question — IM injection versus oral or sublingual — only matters if absorption is a problem. For a healthy thirty-year-old with normal gastric acid production and intact intrinsic factor, oral B12 absorption is adequate enough that supplementation works fine in pill form. The patients who actually need parenteral B12 are the ones with one or more absorption barriers:
Long-term proton pump inhibitor or H2 blocker use. These medications suppress the gastric acid that is required to liberate B12 from food protein. Patients on chronic acid-suppression therapy have meaningfully reduced B12 absorption, and this includes a lot of middle-aged patients who have been on omeprazole or pantoprazole for years.
Metformin use. Metformin is the foundation of type 2 diabetes care for good reason, but chronic use is associated with B12 malabsorption in roughly 10-30% of patients depending on duration and dose. Anyone on metformin for more than two years should have B12 monitored.
Gastric bypass and other bariatric surgery. Roux-en-Y bypass eliminates the section of stomach where intrinsic factor is produced and the section of small intestine where B12 is most efficiently absorbed. Lifelong B12 supplementation — typically by injection — is the standard of care, and patients are sometimes unaware of this requirement.
Pernicious anemia. Autoimmune destruction of intrinsic factor production. Oral B12 essentially does not absorb in these patients. They require lifelong injection.
Inflammatory bowel disease, celiac disease, SIBO. Any condition that compromises absorption surface area or function affects B12.
Strict vegan diet without supplementation. Plant foods do not contain reliable B12. A vegan patient who is not supplementing will eventually develop deficiency.
Age over 60. Atrophic gastritis becomes more common with age, which reduces gastric acid and therefore B12 liberation from food.
When I see a patient with low or low-normal B12, I am asking about every one of these. The answer determines whether the right intervention is dietary, oral, sublingual, intramuscular, or IV — and how often.
The actual bioavailability numbers
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
Here is the part that is often misrepresented in marketing material:
Oral B12 (standard cyanocobalamin tablet, 1000 mcg). Absorption through the intrinsic-factor-mediated pathway is saturated at roughly 1.5-2 mcg per dose. There is also a passive diffusion pathway that absorbs about 1% of any oral dose regardless of intrinsic factor. So a 1000 mcg oral dose delivers about 10-12 mcg total to circulation — enough for most patients with intact gut function, inadequate for many with absorption barriers.
Sublingual B12. Despite the marketing, the absorption advantage of sublingual over oral is much smaller than commonly claimed. Some studies show no meaningful difference. A few show modest improvement. The mucosal absorption is real but limited. For patients with intact intrinsic factor, sublingual works because oral works. For patients without intrinsic factor, sublingual does not solve the problem.
Intramuscular methylcobalamin or hydroxocobalamin injection (1000 mcg). Bypasses the gut entirely. Bioavailability approaches 100% of the injected dose. Methylcobalamin is the active form, which I prefer for most patients over cyanocobalamin (the synthetic form requires a methylation step in the body). The injection is small-volume, well tolerated, and can be done weekly or monthly depending on the indication.
B12 in an IV protocol. Same essential bioavailability as IM, with the IV serving primarily as a vehicle for combined repletion when other indications justify the IV.
For the patient I described at the beginning of this article — long-term PPI use, low-normal serum B12, elevated methylmalonic acid, neurologic symptoms — daily sublingual lozenges had not moved her level meaningfully because her absorption was compromised at the gastric step. A weekly methylcobalamin injection at 1000 mcg for eight weeks brought her level from 198 to over 800, normalized her methylmalonic acid, and resolved her tingling and brain fog over about three months. That is not a placebo response. It is a deficiency that was never appropriately treated by an oral approach.
When I actually recommend B12 injections
When I evaluate a patient and the picture supports it, I recommend IM B12 in these scenarios:
- Documented deficiency (low serum B12, or normal serum B12 with elevated methylmalonic acid)
- Long-term PPI use, chronic metformin, post-bariatric surgery, or known IBD
- Pernicious anemia
- Functional symptoms (neurologic, cognitive, fatigue) in a patient with low-normal B12 and an absorption barrier
- Failure to raise B12 levels with an adequate trial of oral or sublingual supplementation
- Strict vegan patients without reliable absorption certainty
When I do not recommend B12 injections:
- Healthy adults with normal B12 levels and no symptoms — there is no benefit
- Patients seeking a generic "energy boost" without a documented indication — the evidence does not support it as a non-specific stimulant
- Patients who can be adequately repleted with oral supplementation and have no absorption barrier
I want to be straight with patients about this. The wellness market sells B12 injections as a routine pick-me-up. For most healthy patients, that use is a placebo with a needle attached. For patients with actual absorption barriers, the same injection is a genuinely effective intervention that fixes a problem oral supplementation cannot.
How this fits into a real wellness assessment
If you are considering B12 supplementation, the question I want you to start with is not "injection or sublingual?" The question is "what does the lab data actually show, and what is causing it?" Without that information, the choice between delivery routes is guesswork.
A real workup includes serum B12, methylmalonic acid, homocysteine, folate, and a medication and history review that identifies any absorption barriers. From there, the choice between oral, sublingual, and IM becomes a clinical decision rather than a marketing one. IV hydration therapy at our clinics has B12 as one of many additives — and we add it when the indication supports it, not as a default.
The clinical next step
If you have unexplained fatigue, neuropathy, cognitive symptoms, or you are on a long-term PPI, metformin, or have a history of bariatric surgery and have not had a complete B12 workup including methylmalonic acid, that is the conversation worth booking. Bring any prior labs and a complete medication list, including how long you have been on each.
Schedule an infusion or use the comprehensive wellness assessment pathway if you want the workup before deciding on a delivery route. We will look at the data together and recommend the form, dose, and frequency that actually fits your physiology.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.